Medical Technology Industry in
Lausanne

Bracco Injeneering SA

Since 2003 · 1–10 empl.

Bracco Injeneering SA develops, manufactures and markets contrast agents, medical devices and digital solutions for diagnostic imaging, including offerings for X-ray/CT, MRI, ultrasound, nuclear medicine and interventional cardiology.

Argon Medical Devices Switzerland SA

Since 2007 · 11–20 empl.

Argon Medical Devices Switzerland SA manufactures and supplies interventional medical devices and provides related services. Its product range includes thrombectomy systems, biopsy instruments, retrievable vena cava filters, microcatheters and drainage catheters, and the company offers custom product solutions, clinical education and regulatory support.

CRISALIX SA

Since 2008 · 1–10 empl.

The company Crisalix offers 3D and 4D simulations for plastic and aesthetic surgery. It enables patients to virtually visualize their potential results after an operation and surgeons to better advise and support their patients. The company's core activity lies in the development and provision of virtual reality technologies for the medical sector, particularly for plastic and aesthetic surgery.

Aleva Neurotherapeutics SA

Since 2008 · 21–50 empl.

The core activity of Aleva Neurotherapeutics is the development, manufacture and marketing of medical devices for neuromodulation, in particular for deep brain stimulation (DBS) for the treatment of neurological disorders such as Parkinson's disease and essential tremor.

Doc-Invent SA

Since 2008 · 1–10 empl.

The core activity of Doc-Invent SA is the development, manufacture and marketing of innovative medical devices, in particular the product FISSCURE, a CE-certified, unique, single-use medical device for the precise injection of Botulinum toxin into the internal anal ring for the treatment of chronic anal fissures.

Excellness Biotech SA

Since 2009 · 1–10 empl.

Excellness Biotech SA develops biomimetic cell culture substrates with defined elasticity for laboratory use. The company offers soft culture surfaces and wrinkling substrates used to study cell behavior and contraction.

KISANO Suisse SA

Since 2010 · 1–10 empl.

The core activity of Kisano Group is the development and provision of solutions for the healthcare industry, particularly in the field of medical imaging and cancer early detection. The company offers platforms and services to hospitals, radiology departments and research institutions to support the diagnosis and treatment of diseases, especially breast cancer.

Fondation EssentialMed

Since 2010 · 11–20 empl.

The core activity of EssentialMed is the development and provision of medical devices and technologies specifically designed for the needs of people in low and middle-income countries. The company aims to improve healthcare in these countries through innovative and cost-effective solutions.

Laboratoire dentaire Chantal Clerc

Since 2012 · 1–10 empl.

The core activity of Laboratoire dentaire Chantal Clerc is the manufacture and repair of dental prosthetics, including prostheses, dental splints and implants. The company also offers services such as transformation and maintenance of prostheses.

ORTHETHIC Kern SA

Since 2012 · 11–20 empl.

The core activity of Ortho.Kern is the manufacture and sale of orthopedic aids, particularly orthoses, prostheses, orthopedic shoes and podological products. The company offers a wide range of products to support the mobility and comfort of people with orthopedic needs.

Léman Micro Devices SA

Since 2013 · 21–50 empl.

Léman Micro Devices SA develops and commercializes sensor systems and software for medical-grade measurement of vital signs and ECG in mobile devices. The company sells sensors to mobile device manufacturers and also provides services to end users.

Laboratoire Dentaire Damien Porras

Since 2013 · 1–10 empl.

Laboratoire Dentaire Damien Porras manufactures dental prostheses, offering removable, fixed and hybrid (fixed‑removable) restorations. Services include crowns (full‑ceramic), implant‑supported work, metal frameworks, repairs and devices such as Snortec anti‑snoring splints and Gerber face‑bow registrations, and the laboratory provides technical support to practitioners.

PB&B SA

Since 2013 · 1–10 empl.

PB&B SA develops a natural injectable technology for medical aesthetics to remodel facial and body fat tissue by increasing fat cell volume with plant-derived lipids. Its products are currently under clinical investigation and limited to investigational use.

SensArs Neuroprosthetics Sàrl

Since 2014 · 1–10 empl.

The core activity of Sensars is the development and marketing of neurotechnology products, in particular neuroprosthetic systems and neuromodulation-based solutions for the treatment of chronic pain and sensory losses, such as those caused by diabetic neuropathy.

Tandem Diabetes Care Switzerland Sàrl

Since 2014 · 1–10 empl.

Tandem Diabetes Care Switzerland Sàrl develops and sells insulin pumps and related digital solutions for diabetes management. The company offers automated insulin delivery systems, accessories, software and support services for people living with diabetes and healthcare professionals.

Spectroswiss Sàrl

Since 2014 · 1–10 empl.

The core activity of Spectroswiss is the development and provision of software and hardware solutions for mass spectrometry, particularly for Fourier Transform Mass Spectrometry (FTMS). This includes: software tools for data processing and analysis in mass spectrometry; advanced hardware for FTMS data acquisition; and expert consulting, training and contract research organization (CRO) services in the field of FTMS technologies. The company focuses on developing solutions for life sciences, environmental sciences and basic research.

Cygnia Sàrl

Since 2014 · 1–10 empl.

The core activity of Cygnia Sàrl is the mediation and distribution of high-quality Swiss health and wellness products and services to Chinese customers. This includes in particular: The trade in health foods and dietary supplements; The organization of high-quality health tourism in Switzerland, including medical treatments and wellness programs; The implementation of international sports projects and the mediation of contacts between Swiss and Chinese sports organizations; The support of Swiss companies in introducing their products to the Chinese market. In addition, Cygnia also offers services such as visa services, ticket and hotel booking, travel planning and medical consulting.

HEMO PLUS Sàrl

Since 2015 · 1–10 empl.

The core activity of HEMOPLUS is the development and delivery of modular, turnkey structures for the production and packaging of concentrates for haemodialysis.

Pristem SA

Since 2015 · 11–20 empl.

The core activity of Pristem is the development, manufacture and provision of medical imaging equipment, particularly X-ray systems, as well as the establishment and operation of decentralized diagnostic centers in remote regions. The goal is to improve access to medical imaging procedures, especially X-ray examinations, in areas with limited access to medical care, thereby strengthening healthcare in these regions.

Intento SA

Since 2016 · 1–10 empl.

The core activity of Intento is the development and provision of digital therapeutic solutions for the rehabilitation of patients with upper limb impairments after stroke. In particular, the company focuses on developing solutions based on Self-Modulated Functional Electrical Stimulation to improve patients' mobility.

ADIS SA

Since 2016 · 11–20 empl.

The core activity of Adis SA is the development and provision of innovative medical imaging products and software based on artificial intelligence (AI) and augmented reality (AR), designed to support medical personnel during various interventions and operations, particularly in the fields of cardiology, oncology, and interventional radiology.

Resilient SA

Since 2017 · 11–20 empl.

The company offers solutions for burnout and chronic stress among employees. It develops and implements programs based on data analysis and artificial intelligence to promote the mental health and resilience of employees. The company's core activity is in the field of health promotion and prevention in the workplace, particularly through the application of digital technologies and expert knowledge from psychiatry and psychotherapy.

Comphya SA

Since 2017 · 11–20 empl.

The core activity of Comphya SA is the development and marketing of medical devices and technologies, particularly in the field of neuroprosthetics and the treatment of erectile dysfunction. The company focuses on the development of implantable devices that can restore natural penile erection through wireless external controls.

Aesyra SA

Since 2017 · 11–20 empl.

The core activity of Venturelab is to support startups and innovators in Switzerland and beyond by providing them with access to resources, knowledge, tools, and funding to facilitate their entrepreneurial journey. This includes organizing training sessions, workshops, and events, facilitating connections with investors and companies, and promoting business development and international expansion. Venturelab offers specific programs and initiatives, such as Venture Kick, Innosuisse Start-up Trainings, Venture Leaders, and the TOP 100 Swiss Startup Award, to support startups on their path to success.

Vanarix SA

Since 2018 · 11–20 empl.

The core activity of Vanarix SA is the development and production of cell therapies, in particular bioengineered cartilage transplants called Cartibeads, for the repair of cartilage defects and the treatment of osteoarthritis.

Annaida Technologies SA

Since 2018 · 11–20 empl.

The core activity of Annaida Technologies SA is the development and application of micro-NMR technologies (Micro-MRS) for various applications, particularly in the fields of reproductive health, in-vitro toxicology and drug discovery as well as life science research.

Pi Imaging Technology SA

Since 2018 · 1–10 empl.

The core activity of Pi Imaging Technology is the development and manufacture of photon-counting arrays with the highest sensitivity and lowest noise, particularly based on Single-Photon Avalanche Diodes (SPADs). This technology is used in various applications such as life sciences, quantum computing, confocal microscopy, and high-speed imaging. The company offers standardized products like SPAD23, SPAD 512², and SPADλ, as well as customer-specific sensors and systems.

NextKidney SA

Since 2020 · 1–10 empl.

The core activity of Nextkidney is the development and manufacture of portable home hemodialysis devices for patients with kidney failure, with the aim of giving patients more freedom and independence in their treatment.

Readily3D SA

Since 2020 · 11–20 empl.

The core activity of Readily3D is the development and manufacturing of volumetric 3D printers, particularly for biotechnology and the production of living tissue. The company also offers related software and services, such as the development of custom tools and protocols for clients.

Aimmax Medical SA

Since 2021 · 11–20 empl.

The core activity of Aimmax Medical SA is the manufacture and distribution of medical products, particularly single-use medical products such as masks, protective clothing, bandages and other medical accessories. The company also produces products such as slippers, dialysis sets and toilet articles. The products are distributed both in Switzerland and internationally, particularly in Europe, the USA, Africa and Southeast Asia.

MOTILIS MEDICA SA

Since 2009 · 1–10 empl.

Biospectal SA

Since 2017 · 11–20 empl.

The core activity of Biospectal SA is the development of digital health software and medical devices, particularly in the field of blood pressure measurement and monitoring. The company focuses on solving real-world problems related to patient access to medical solutions and develops products and services based on artificial intelligence (AI).

ardosdentaire, Ardos Balogh

Since 2013 · 1–10 empl.

ardosdentaire, Ardos Balogh provides dental technician services as presented on the website. Contact details, including an email address and telephone number, are listed on the site.

Damant Management SA

Since 2019 · 1–10 empl.

Damant Management SA supplies medical products and services to healthcare institutions, government clients and international clinical facilities. Its activities include a micro-bioreactor platform for clinical testing, medical support and personal protective equipment.

Dräger Schweiz SA

Since 1985 · 11–20 empl.·3.6(7)

Dräger Schweiz SA provides medical and safety technology for hospitals, industry, and fire services. Its portfolio includes ventilation and monitoring systems, gas detection technology, respiratory protection, and related services and training.

Axontronic Brandmeier

Since 2018 · 1–10 empl.

The core activity of Axontronic is to provide solutions and services in the field of clinical and surgical neurophysiology, particularly in intraoperative neuromonitoring (IONM). This includes: * Representing and distributing products from leading global companies, such as neuromonitoring systems, neurocartography systems, EEG and EP systems, as well as accessories and electrodes. * Providing clinical services, such as deploying experienced neurophysiologists or neurologists in operating rooms to offer intraoperative neuromonitoring services. * Conducting training sessions and workshops for customers to instruct them on the application of products and services. * Providing technical support and maintenance for products, including preventive maintenance, safety inspections, repairs, and remote support. The company focuses on markets in Germany, Austria, and Switzerland, but also collaborates with partners in other regions.

Viventis Microscopy Sàrl

Since 2017 · 1–10 empl.

GenomSys SA

Since 2016 · 11–20 empl.·4.3(6)

GenomSys SA develops software solutions for genomic data processing and applications compliant with the ISO/IEC 23092 (MPEG‑G) standard. Its product portfolio includes the GenomSys MPEG‑G Toolkit, a cloud‑native secondary analysis platform and vertical applications such as the GenomSys Variant Analyzer and GenomSys Blood Typer; the company is ISO‑13485 certified and provides cloud and on‑premise deployments.